We are live on ! Find out more
ETTX

Entasis Therapeutics Holdings Inc.
ETTX

Delisted

ETTX was delisted on the 8th of July, 2022.

Back to rankings

17 hedge funds and large institutions have $57.5M invested in Entasis Therapeutics Holdings Inc. in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more capital invested

Capital invested by funds: $34.8M → $57.5M (+$22.7M)

15% less funds holding

Funds holding: 20 → 17 (-3)

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
17
Holders Change
-3
Holders Change %
-15%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
+$7.93K
2
Wells Fargo
Wells Fargo
California
+$3K
3
TFS
TrustCore Financial Services
Tennessee
+$599

Top Sellers

Rank Fund Capital Flow
1
Stifel Financial
Stifel Financial
Missouri
-$86K
2
FIA
FNY Investment Advisers
New York
-$56K
3
Millennium Management
Millennium Management
New York
-$17.3K
4
UBS Group
UBS Group
Switzerland
-$15.2K
5
PAM
Panagora Asset Management
Massachusetts
-$11.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
NHAS
1
Novo Holdings A/S
Denmark
$14.7M – – –
Blackstone Inc
2
Blackstone Inc
New York
$11M – – –
FM
3
Frazier Management
Washington
$9.12M – – –
SI
4
Sofinnova Investments
California
$7.97M – – –
TGHSA
5
TPG Group Holdings (SBS) Advisors
Texas
$6.9M – – –
EAM
6
Eventide Asset Management
Massachusetts
$5.78M – – –
GIM
7
Granahan Investment Management
Massachusetts
$977K -$7.55K -1,261 -0.9%
Vanguard Group
8
Vanguard Group
Pennsylvania
$332K – – –
Janney Montgomery Scott
9
Janney Montgomery Scott
Pennsylvania
$289K +$7.93K +1,323 +3%
Millennium Management
10
Millennium Management
New York
$211K -$17.3K -2,893 -8%
BlackRock
11
BlackRock
New York
$87K -$5.28K -882 -6%
PAM
12
Panagora Asset Management
Massachusetts
$56K -$11.9K -1,981 -19%
Wells Fargo
13
Wells Fargo
California
$44K +$3K +500 +8%
UBS Group
14
UBS Group
Switzerland
$22K -$15.2K -2,534 -43%
OIA
15
OneDigital Investment Advisors
Kansas
$8K – – –
TRCT
16
Tower Research Capital (TRC)
New York
$7K -$1.92K -320 -23%
TFS
17
TrustCore Financial Services
Tennessee
$1K +$599 +100 New
Stifel Financial
18
Stifel Financial
Missouri
– -$86K -21,250 Closed
FIA
19
FNY Investment Advisers
New York
– -$56K -13,901 Closed

ETTX Hedge Fund Activity: Q1 2019 in Review

17 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Entasis Therapeutics Holdings Inc. (ETTX) for Q1 2019, worth a combined $57.5M — up 65% from $34.8M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of ETTX and 1 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 2 added.

The largest buyer was Janney Montgomery Scott, adding an estimated $7.93K. The largest seller was Stifel Financial, exiting entirely with an estimated $86K sold.

  • 17 institutional investors held Entasis Therapeutics Holdings Inc. (ETTX) as of Q1 2019, down from 20 in Q4 2018.
  • Funds reported $57.5M of Entasis Therapeutics Holdings Inc. stock for Q1 2019, up 65% quarter-over-quarter.
  • 1 fund opened new Entasis Therapeutics Holdings Inc. positions in Q1 2019 and 4 closed out, a net change of -3 holders.
  • The largest Entasis Therapeutics Holdings Inc. buyer in Q1 2019 was Janney Montgomery Scott, an estimated $7.93K added.
  • The largest Entasis Therapeutics Holdings Inc. seller in Q1 2019 was Stifel Financial, an estimated $86K sold.

Based on aggregated 13F filings for Q1 2019.